Nancy Mckinstry's Insider Trades & SAST Disclosures
Nancy Mckinstry's most recent trade in Accenture plc - Ordinary Shares - Class A was a trade of 4 Class A ordinary shares done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nancy Mckinstry.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 4 | 7,255 (0%) | 0% | 0 | Class A ordinary shares | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 1,635 | 38,724 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2025 | 1,465 | 1,465 | - | - | Option (right to buy) | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 4 | 7,253 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 389.00 per share. | 14 Feb 2025 | 2 | 7,251 (0%) | 0% | 389 | 778 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 813 | 7,249 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 383.32 per share. | 31 Jan 2025 | 419 | 6,436 (0%) | 0% | 383.3 | 160,611 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 4 | 6,855 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 4 | 6,851 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 4 | 6,847 (0%) | 0% | 0 | Class A ordinary shares | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 6,850 | 6,850 | - | - | Option (right to buy) | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 1,866 | 37,089 (0%) | 0% | 0 | Common shares without par value | |
| Accenture plc - Ordinary S... | Mckinstry Nancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4 | 6,845 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 372.50 per share. | 15 Feb 2024 | 2 | 6,843 (0%) | 0% | 372.5 | 745 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Mckinstry Nancy | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 367.33 per share. | 01 Feb 2024 | 549 | 6,841 (0%) | 0% | 367.3 | 201,665 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Mckinstry Nancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 859 | 7,390 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 5 | 6,531 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 5 | 6,526 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 5 | 6,521 (0%) | 0% | 0 | Class A ordinary shares | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 9,861 | 9,861 | - | - | Option (right to buy) | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 1,816 | 35,223 (0%) | 0% | 0 | Common shares without par value | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 4 | 6,518 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 285.00 per share. | 15 Feb 2023 | 2 | 6,516 (0%) | 0% | 285 | 570 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 1,127 | 6,514 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 274.10 per share. | 26 Jan 2023 | 400 | 5,387 (0%) | 0% | 274.1 | 109,639 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 4 | 5,787 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 3 | 5,783 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 4 | 5,780 (0%) | 0% | 0 | Class A ordinary shares | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 7,846 | 7,846 | - | - | Option (right to buy) | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 1,602 | 33,407 (0%) | 0% | 0 | Common shares without par value | |
| Abbott Laboratories | Nancy Mckinstry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.84 per share. | 24 Feb 2022 | 6,280 | 33,419 (0%) | 0% | 29.8 | 187,394 | Common shares without par value |
| Abbott Laboratories | Nancy Mckinstry | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2022 | 6,280 | 0 | - | - | Option (right to buy) | |
| Abbott Laboratories | Nancy Mckinstry | Director | Sale of securities on an exchange or to another person at price $ 116.43 per share. | 24 Feb 2022 | 1,614 | 31,805 (0%) | 0% | 116.4 | 187,910 | Common shares without par value |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 4 | 5,778 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 330.50 per share. | 15 Feb 2022 | 2 | 5,776 (0%) | 0% | 330.5 | 661 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 347.95 per share. | 03 Feb 2022 | 566 | 5,774 (0%) | 0% | 348.0 | 196,941 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 911 | 6,340 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 4 | 5,429 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2021 | 4 | 5,425 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 4 | 5,421 (0%) | 0% | 0 | Class A ordinary shares | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 7,035 | 7,035 | - | - | Option (right to buy) | |
| Abbott Laboratories | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2021 | 1,499 | 27,139 (0%) | 0% | 0 | Common shares without par value | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 4 | 5,419 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 257.00 per share. | 12 Feb 2021 | 2 | 5,417 (0%) | 0% | 257 | 514 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 1,167 | 5,415 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.48 per share. | 30 Jan 2021 | 517 | 4,248 (0%) | 0% | 245.5 | 126,913 | Class A ordinary shares |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2020 | 4 | 4,765 (0%) | 0% | 0 | Class A ordinary shares | |
| Accenture plc - Ordinary S... | Nancy Mckinstry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 4 | 4,761 (0%) | 0% | 0 | Class A ordinary shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges